<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03957499</url>
  </required_header>
  <id_info>
    <org_study_id>Beni-Suef Faculty of Medicine</org_study_id>
    <nct_id>NCT03957499</nct_id>
  </id_info>
  <brief_title>Analgesic Efficacy of Fascia Iliaca Compartment Block</brief_title>
  <official_title>Analgesic Efficacy of Fascia Iliaca Compartment Block With Bupivacaine Versus Bupivacaine With Dexamethasone or Magnesium Sulphate for Dynamic Hip Screw Surgeries Randomized Double Blinded Comparative Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samaa Rashwan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beni-Suef University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the analgesic efficacy of fascia iliaca compartment
      block using bupivacaine versus bupivacaine with dexamethasone or magnesium sulphate for
      dynamic hip screw surgery under spinal anesthesia.

      The primary outcome will be the duration of effective analgesia from FICB till the first
      analgesic dose is required,the secondary outcomes will be the severity of postoperative pain
      as will be assessed by the visual analogue scale and the total dose of pethidin for rescue
      analgesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Different modes of analgesia are given prior to neuraxial blockade for pain relief like
      non-steroidal anti-inflammatory drugs (NSAID), opioids and peripheral nerve blocks such as,
      femoral nerve block, 3 in 1 block or fascia iliaca compartment block (FICB).

      FICB is believed to be most beneficial compared to other procedures because of its safety and
      efficacy . FICB provides blockage of at least two of the three major nerves that supply the
      medial, anterior and lateral thigh with one simple injection, namely the femoral and lateral
      femoral cutaneous nerves.

      FICB is an anterior approach to the lumbar plexus. The pop technique using fascial click had
      a low success rate of 35% - 47% .However, as the FICB was performed under real-time
      ultrasound guidance, the success rate was increased up to 82- 87%, leading to an increased
      interest in FICB as a postoperative analgesia option for hip and knee surgical procedures .
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">May 2019</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
    <masking_description>The anesthetists who will prepare the drug and who will collect the data will be blinded to the study protocol</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Analgesia</measure>
    <time_frame>duration from the end of surgery till the first time to ask for post operative analgesia within the first 12 hours after surgery</time_frame>
    <description>the duration of effective analgesia will be considered as the duration after performing the FICB till the patient ask for first analgesic dose ,in this case pethidin 25 mg will be given intravenously</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Analgesia</condition>
  <arm_group>
    <arm_group_label>the control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Ultrasound guided fascia iliaca compartment block (FICB) will be performed using 28 ml bupivacaine 0.25% + 2 ml of normal saline (total volume 30 ml).(</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group dexamethasone/Bupivacaine:</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ultrasound guided fascia iliaca compartment block (FICB) will be performed using with 28 ml bupivacaine 0.25% + 2 ml dexamethasone (8mg) (total volume 30 ml).(</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group Magnesium sulphate/Bupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ultrasound guided fascia iliaca compartment block (FICB) will be performed using 28 ml bupivacaine 0.25% + 2 ml magnesium sulphate (200mg) (total volume 30 ml).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>Ultrasound guided fascia iliaca compartment block (FICB) will be performed using 28 ml bupivacaine 0.25% + 2 ml of normal saline (total volume 30 ml).(</description>
    <arm_group_label>the control group</arm_group_label>
    <other_name>Marcain</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone/bupivacaine</intervention_name>
    <description>Ultrasound guided fascia iliaca compartment block (FICB) will be performed with 28 ml bupivacaine 0.25% + 2 ml dexamethasone (8mg) (total volume 30 ml)d using</description>
    <arm_group_label>Group dexamethasone/Bupivacaine:</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Magnesium Sulfate/bupivacaine</intervention_name>
    <description>Ultrasound guided fascia iliaca compartment block (FICB) will be performed using 28 ml bupivacaine 0.25% + 2 ml magnesium sulphate (200mg) (total volume 30 ml).</description>
    <arm_group_label>Group Magnesium sulphate/Bupivacaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiology physical status (ASA) I &amp; II of both sex.

          -  Age between 20 and 70 years.

          -  Patients with traumatic hip fracture presenting for elective or emergency dynamic hip
             screw (DHS) fixation under spinal anesthesia.

        Exclusion Criteria:

          -  Patient refused to give consent

          -  Patients with history of allergy to dexamethasone, magnesium sulphate or bupivacaine.

          -  Patients with contraindications to spinal anesthesia.

          -  Previous surgery in the affected hip, infection at the injection site, multiple
             fractures.

          -  Peripheral neuropathy.

          -  Use of analgesics within 8 hours before the spinal block.

          -  Inguinal hernia, and femoral artery graft.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Samaa Rashwan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assisstant proffesor of anesthesia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Samaa Rashwan, MD</last_name>
    <phone>020120159125</phone>
    <email>samakassemrashwan@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Beni-Suef University Hospital</name>
      <address>
        <city>BanÄ« Suwayf</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samaa Rashwan, MD</last_name>
      <phone>0201270159125</phone>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 13, 2019</study_first_submitted>
  <study_first_submitted_qc>May 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 21, 2019</study_first_posted>
  <last_update_submitted>May 19, 2019</last_update_submitted>
  <last_update_submitted_qc>May 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Beni-Suef University</investigator_affiliation>
    <investigator_full_name>Samaa Rashwan</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Magnesium Sulfate</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

